Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mehmet Sofuoglu

Showing results (31-40 of 197) with videos related to

Pageof 20
Sort By:
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|December 12, 2003
Labetalol treatment enhances the attenuation of tobacco withdrawal symptoms by nicotine in abstinent smokersMehmet Sofuoglu, David Babb, Dorothy K Hatsukami
Pharmacology, Biochemistry, and Behavior|August 11, 2004
Effects of progesterone treatment on cocaine responses in male and female cocaine usersMehmet Sofuoglu, Ellen Mitchell, Thomas R Kosten
The American Journal on Addictions|April 3, 2009
The effect of cannabis compared with alcohol on drivingR Andrew Sewell, James Poling, Mehmet Sofuoglu
Addictive Behaviors|November 12, 2017
Tobacco and alcohol use disorders: Evaluating multimorbidityR Ross MacLean, Mehmet Sofuoglu, Robert Rosenheck
British Journal of Clinical Pharmacology|August 21, 2024
Sex differences in comorbid pain and opioid use disorder: A scoping reviewElise E DeVito, Victoria Ameral, Mehmet Sofuoglu
Evidence-Based Medicine|March 12, 2011
Varenicline increases smoking abstinence at 6 months to a year compared with placebo or bupropion; nausea is the most commonly reported adverse effectMehmet Sofuoglu, Dianne Duffey, Marc E Mooney
Expert Review of Clinical Pharmacology|March 6, 2025
Nicotine e-cigarettes for smoking cessation: a clinical pharmacology perspectiveVictoria Ameral, Mehmet Sofuoglu, Megan M Kelly
Addictive Behaviors|December 25, 2018
E-cigarette nicotine dose and flavor: Relationship with appeal, choice, and tobacco use amongst veterans with comorbid psychiatric disordersElise E DeVito, Eugenia Buta, Mehmet Sofuoglu
Pharmacology, Biochemistry, and Behavior|December 24, 2010
The safety of modafinil in combination with oral ∆9-tetrahydrocannabinol in humansDawn E Sugarman, James Poling, Mehmet Sofuoglu
The American Journal of Drug and Alcohol Abuse|May 15, 2007
Treatment outcome predictors for cocaine dependenceJames Poling, Thomas R Kosten, Mehmet Sofuoglu
Pageof 20

Showing results (31-40 of 197) with videos related to

Sort By:
Pageof 20
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|December 12, 2003
Labetalol treatment enhances the attenuation of tobacco withdrawal symptoms by nicotine in abstinent smokersMehmet Sofuoglu, David Babb, Dorothy K Hatsukami
Pharmacology, Biochemistry, and Behavior|August 11, 2004
Effects of progesterone treatment on cocaine responses in male and female cocaine usersMehmet Sofuoglu, Ellen Mitchell, Thomas R Kosten
The American Journal on Addictions|April 3, 2009
The effect of cannabis compared with alcohol on drivingR Andrew Sewell, James Poling, Mehmet Sofuoglu
Addictive Behaviors|November 12, 2017
Tobacco and alcohol use disorders: Evaluating multimorbidityR Ross MacLean, Mehmet Sofuoglu, Robert Rosenheck
British Journal of Clinical Pharmacology|August 21, 2024
Sex differences in comorbid pain and opioid use disorder: A scoping reviewElise E DeVito, Victoria Ameral, Mehmet Sofuoglu
Evidence-Based Medicine|March 12, 2011
Varenicline increases smoking abstinence at 6 months to a year compared with placebo or bupropion; nausea is the most commonly reported adverse effectMehmet Sofuoglu, Dianne Duffey, Marc E Mooney
Expert Review of Clinical Pharmacology|March 6, 2025
Nicotine e-cigarettes for smoking cessation: a clinical pharmacology perspectiveVictoria Ameral, Mehmet Sofuoglu, Megan M Kelly
Addictive Behaviors|December 25, 2018
E-cigarette nicotine dose and flavor: Relationship with appeal, choice, and tobacco use amongst veterans with comorbid psychiatric disordersElise E DeVito, Eugenia Buta, Mehmet Sofuoglu
Pharmacology, Biochemistry, and Behavior|December 24, 2010
The safety of modafinil in combination with oral ∆9-tetrahydrocannabinol in humansDawn E Sugarman, James Poling, Mehmet Sofuoglu
The American Journal of Drug and Alcohol Abuse|May 15, 2007
Treatment outcome predictors for cocaine dependenceJames Poling, Thomas R Kosten, Mehmet Sofuoglu
Pageof 20